Boston Scientific Corporation (BSX) Cash Flow Statement

The persistent premium of operating cash flow over net income suggests strong underlying cash generation from core operations, driven by non-cash items like depreciation and amortization. However, the significant quarterly volatility in the OCF/NI ratio, particularly the sharp drop in 2026Q1, highlights that working capital swings can temporarily obscure the quality of earnings, warranting a closer look at the underlying drivers of receivables and inventory.

The strong FCF trajectory, particularly the recent expansion to a 23.5% margin, aligns with the reported revenue growth and gross margin expansion, suggesting the business is scaling efficiently. The comparison to net income shows that FCF is often multiples of reported earnings, reinforcing the view that the company's cash generation power is a key strength, though the negative FCF in 2024Q1 serves as a reminder of the impact of large working capital or acquisition-related cash outflows.

The erratic pattern of working capital changes, swinging from large negative to positive figures quarter-to-quarter, suggests that the timing of receivables collection and inventory management creates significant noise in the cash flow statement. This volatility makes it difficult to assess the underlying trend in operational efficiency and implies that investors should focus on the longer-term average rather than any single quarter's working capital impact.

The consistently low capital intensity, with CapEx/Rev averaging around 4.2%, suggests that Boston Scientific's business model does not require heavy reinvestment to sustain operations, which is a key enabler of its strong free cash flow margins. This level of spending appears sufficient to maintain and grow the asset base, as evidenced by the steady depreciation and amortization figures, without consuming excessive cash.

The capital deployment pattern reveals a clear priority on strategic acquisitions to drive growth, as seen in the large, episodic cash outflows for net acquisitions. The recent $2.0 billion buyback in 2026Q2, following a period of minimal repurchase activity, suggests a shift towards returning capital to shareholders, but this must be balanced against the ongoing need for acquisition funding and the volatility in operating cash flow.